| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 02/11/1997 | US5602005 Antigen remains associated with primate sperm after acrosome reaction |
| 02/11/1997 | US5601973 Polypeptides for diagnostic identifying specific antibodies |
| 02/11/1997 | US5601831 Vaccines for nontypable Haemophilus influenzae |
| 02/11/1997 | US5601827 Replacing or deleting certain codons of naturally-occuring diphtheria toxin |
| 02/11/1997 | US5601822 γ, δ T cell receptor and methods for detection |
| 02/11/1997 | US5601821 Histamine releasing peptide |
| 02/06/1997 | WO1997004109A1 α-β C4BP-TYPE RECOMBINANT HETEROMULTIMERIC PROTEINS |
| 02/06/1997 | CA2227030A1 .alpha.-.beta. c4bp-type recombinant heteromultimeric proteins |
| 02/05/1997 | EP0757100A1 Over-expression and purification of a truncated thermostable DNA polymerase by protein fusion |
| 02/05/1997 | EP0757099A2 CTLA4 mutant molecules and uses thereof |
| 02/05/1997 | EP0756490A1 Human bone stimulating factor |
| 02/04/1997 | US5599904 Encoded by dna carried on plsmid; glucocorticoid/mineralocorticoid/thyroid hormone/retinoic acid and estrogen related receptors |
| 02/04/1997 | US5599679 A polypeptide for immuno-competing binding; immunoassay diagnosing bone disorder |
| 02/04/1997 | US5599678 Antibodies which react with fibrinogen fragments E1, E2 and E3 and methods of their use |
| 02/04/1997 | US5599677 Immunoassays for prostate specific antigen |
| 02/04/1997 | US5599542 Diagnosis, treatment and vaccine for malaria; induction of antibodies that attack plasmodium in the schizont stage |
| 01/30/1997 | WO1997003188A2 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 01/30/1997 | WO1996039425A3 Compounds having bradykinin antagonistic activity and mu-opioid agonistic activity |
| 01/29/1997 | EP0755259A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON |
| 01/28/1997 | US5597570 Protein recognized by antibodies raised against native P28 of schistosoma mansoni |
| 01/23/1997 | WO1997002354A1 INTERACTION OF p53 WITH TRANSCRIPTION FACTOR DP-1 |
| 01/23/1997 | WO1996040944A3 Fused soluble mhc heterodimer:peptide complexes and their uses |
| 01/23/1997 | WO1996040915A3 Novel ctla4/cd28 ligands and uses therefor |
| 01/23/1997 | CA2224940A1 Interaction of p53 with transcription factor dp-1 |
| 01/22/1997 | EP0754231A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 01/22/1997 | EP0754227A1 Chimeric complement inhibitor proteins |
| 01/22/1997 | EP0502107B1 Type-b rotavirus cultures and uses thereof |
| 01/22/1997 | EP0461200B1 Modified forms of reproductive hormones |
| 01/22/1997 | CN1141061A Thrombopoietin |
| 01/21/1997 | US5595887 Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment |
| 01/21/1997 | US5595741 Aminoalkylmaleimides and hapten and antigen derivatives derived therefrom as well as conjugates with peptides or proteins |
| 01/16/1997 | WO1997001642A1 Modified proteins and methods of their production |
| 01/16/1997 | WO1997001640A2 Vaccines against hepatitis c |
| 01/16/1997 | WO1997001636A2 Recombinant mistletoe lectin |
| 01/16/1997 | WO1996036702A3 Soluble, active hepatitis c virus protease |
| 01/16/1997 | DE19525416A1 Verwendung von MP52 zur Behandlung und Prävention von Erkrankungen des Nervensystems Use of MP52 for the treatment and prevention of diseases of the nervous system |
| 01/16/1997 | CA2222456A1 Vaccines against hepatitis c |
| 01/15/1997 | EP0753073A1 Heat-inducible n-degron module |
| 01/15/1997 | EP0753071A1 Cell-targeted lytic pore-forming agents |
| 01/15/1997 | EP0753069A1 Gene delivery fusion proteins |
| 01/15/1997 | EP0753059A1 Peptide production as fusion protein in transgenic mammal milk |
| 01/15/1997 | EP0752886A1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| 01/15/1997 | EP0752874A1 Enhanced virus-mediated dna transfer |
| 01/15/1997 | EP0752853A1 Human brain phosphodiesterase |
| 01/14/1997 | US5593882 Selectin variants |
| 01/09/1997 | WO1996034088A3 Control of floral induction in plants and uses therefor |
| 01/08/1997 | EP0752477A2 Expression vectors that produce steroid receptors, steroid receptor chimera, screening assays for steroid receptors and clinical assays using synthesized receptors and receptor vectors |
| 01/08/1997 | EP0752426A2 Synthetic calibrators for use in immunoassays, consisting of analytes or parts thereof conjugated to inert carrier molecules |
| 01/08/1997 | EP0752425A2 Peptide ligands for the constant region of immunoglobulins |
| 01/08/1997 | EP0752005A1 Compacted nucleic acids and their delivery to cells |
| 01/08/1997 | EP0751786A1 Urease-based vaccine and treatment for helicobacter infection |
| 01/08/1997 | EP0751782A1 Methods for altering fertility |
| 01/08/1997 | EP0751781A1 Method of preventing or treating disease characterized by neoplastic cells expressing cd40 |
| 01/08/1997 | EP0386166B1 PROTAMINE-REACTIVE IgM ANTIBODIES |
| 01/07/1997 | US5591828 Genetic engineering |
| 01/07/1997 | US5591631 Anthrax toxin fusion proteins, nucleic acid encoding same |
| 01/03/1997 | WO1997000319A2 Chimeric leptin fused to immunoglobulin domain and use |
| 01/03/1997 | WO1996037621A3 Multimeric proteins |
| 01/03/1997 | WO1996034965A3 Chimeric mcp and daf proteins with cell surface localizing domain |
| 01/03/1997 | CA2224646A1 Chimeric leptin fused to immunoglobulin domain and use |
| 01/02/1997 | EP0751221A1 Recombinant mistletoe lectin (rML) |
| 01/02/1997 | EP0750666A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS |
| 01/02/1997 | EP0750626A1 Corpuscles of stannius protein, stanniocalcin |
| 01/02/1997 | EP0750458A1 Terminal complement inhibitor fusion genes and proteins |
| 01/02/1997 | EP0750457A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells |
| 12/31/1996 | US5589384 Formation of pentamer complex and binding to gangliosides and hinges of glycineproline and antigens or epitopes |
| 12/31/1996 | US5589362 Fusion proteins, eukaryotic cells |
| 12/31/1996 | US5589359 Chimeric proteins |
| 12/31/1996 | US5589345 Leukemia cells |
| 12/31/1996 | US5589343 Antibodies which bind to molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by P. falciparum in hepatocytes |
| 12/31/1996 | CA2180280A1 Adenyl-cyclase-hemolysin (ac-hly)-protecting epitopes; use thereof for the treatment or the prevention of infections by bordetella |
| 12/31/1996 | CA1338824C Hypoglycemic and growth-promoting agent isolated from bacitracin |
| 12/27/1996 | WO1996042016A1 Use of a phycobiliprotein-binding peptide complex as a fluorescent tracer |
| 12/27/1996 | EP0749444A1 Hybrid human/animal factor viii |
| 12/27/1996 | EP0749317A1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 12/27/1996 | CA2224146A1 Improved pharmaceutical compositions for gene therapy |
| 12/25/1996 | CN1138863A Chimeric proteins which block complement activation |
| 12/19/1996 | WO1996040960A1 A method for promoting enzyme diversity |
| 12/19/1996 | WO1996040944A2 Fused soluble mhc heterodimer:peptide complexes and their uses |
| 12/19/1996 | WO1996040915A2 Novel ctla4/cd28 ligands and uses therefor |
| 12/19/1996 | WO1996040892A1 Tetracycline regulated transcriptional modulators with altered dna binding specificities |
| 12/19/1996 | WO1996040890A1 Non-naturally occurring targeted lipolytic compounds: synthesis, demonstration of potency, and practical and therapeutic applications |
| 12/19/1996 | WO1996040885A2 β-SECRETASE, ANTIBODIES TO β-SECRETASE, AND ASSAYS FOR DETECTING β-SECRETASE INHIBITION |
| 12/19/1996 | WO1996040881A1 Fucosyltransferase genes and uses thereof |
| 12/19/1996 | WO1996040789A1 THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-Fc RECEPTOR ANTIBODIES |
| 12/19/1996 | WO1996040788A1 Anti-allergy bispecific molecules |
| 12/19/1996 | WO1996040724A1 Recombinational cloning using engineered recombination sites |
| 12/19/1996 | WO1996040719A1 Endothelial-monocyte activating polypeptide iii |
| 12/19/1996 | WO1996040718A1 Expression of lipoproteins |
| 12/19/1996 | WO1996040219A1 Inhibin compositions and methods of enhancing production performance |
| 12/19/1996 | WO1996036722A3 Embedded expression of heterologous proteins |
| 12/19/1996 | CA2704354A1 Expression of lipoproteins |
| 12/19/1996 | CA2226463A1 Recombinational cloning using engineered recombination sites |
| 12/19/1996 | CA2224205A1 Fused soluble mhc heterodimer-peptide complexes and their uses |
| 12/19/1996 | CA2223577A1 Chimeric antibodies for delivery of antigens to selected cells of the immune system |
| 12/19/1996 | CA2223440A1 Fucosyltransferase genes and uses thereof |
| 12/19/1996 | CA2222999A1 Novel ctla4/cd28 ligands and uses therefor |
| 12/19/1996 | CA2222947A1 Inhibin compositions and methods of enhancing production performance |
| 12/19/1996 | CA2221821A1 Endothelial-monocyte activating polypeptide iii |
| 12/19/1996 | CA2220952A1 Anti-allergy bispecific molecules |